As New Jersey reaches the midpoint of autumn, state health officials have already reported an exponential increase in respiratory syncytial virus this season, while continuing to protect a heavy flu season and with the lingering threat of the ever-evolving COVID-19.

Against that backdrop, an ABC News report on Monday that the U.S. Food & Drug Administration is monitoring a shortage of a powder form of the antibiotic amoxicillin, used for oral suspensions, may appear troubling.

The ABC report said amoxicillin is not used as a treatment for RSV, COVID, or the flu, but because it is commonly prescribed for ear infections, strep, and whooping cough, the shortage may require parents to either search around for availability or request an alternative medication from their providers.

Beach Radio logo
Get our free mobile app

The FDA's website first posted the shortage on Friday, indicating that among five different manufacturers, only East Brunswick-based Rising Pharma had the drug on "available" status, with Hikma Pharmaceuticals listing it as available for current customers.

Aurobindo, Sandoz, and Teva reported either limited availability, "on allocation" status, or said amoxicillin was currently unavailable.

The website for the American Society of Health-System Pharmacists said Hikma, Sandoz, and Teva have not provided reasons for the shortage, while Aurobindo refused to provide availability information.

Rising Pharma told ASHP it had capsules and tablets available in lieu of oral suspension powder.

According to ABC, CVS has observed "isolated" shortages of amoxicillin so far, while Walgreens notes no "constraints around availability" at this time.

Patrick Lavery is a reporter and anchor for New Jersey 101.5. You can reach him at

Click here to contact an editor about feedback or a correction for this story.

How is it still standing? Look inside the oldest home for sale in NJ

New Jersey's oldest house is located on Gloucester County and dates back to the 1600's

How much does the average NJ home cost? Median prices by county

Everything is costing more these days — and housing is certainly no exception in New Jersey.

Data for 2022 from January through August, compiled by New Jersey Realtors, shows that South Jersey has been seeing homes hit the market and sell in less than a month, on average.

Median prices for single-family homes have reached $500,000 and above in nine counties in North and Central Jersey.

All but two counties have seen houses go for more than the list price, on average, this year.

New Jersey's Most Terrifying Serial Killers

New Jersey Nightmares - Notorious Serial Killers

More From Beach Radio